Klaus Egner studied physics at the TU Darmstadt. After graduating with a degree in engineering, he trained technical business economist while working. Since 1998, Mr. Egner has been working for Merck KGaA, initially in the Automation department, where he was responsible for laboratories and in the field of chemistry. In 2004, his area of responsibility changed to the pharmaceuticals division with different areas of support (MES, production and packaging solids). In 2011, the implementation of Track & Trace in the packaging sector became step-by-step his main focus. Since Aug. 2019, he has been responsible for Track & Trace in packaging in a global function at Merck Healthcare KGaA.

The Pop in Your Job: I like digging deep into technical complexity to understand finally the full picture and making things operational. Learning about the interaction of technical and multi stakeholder based complexity provides an interesting extra layer for me.

Global Business Process Owner / Business System Owner Shopfloor Serialization.

Global Serialization Expert

Melanie is working in Supply Chain Excellence and has specialized in the area of Track&Trace for the past 4 years.

In her role she is coordinating the successful implementation of new Track&Trace country requirements in close collaboration with the local country organizations and global functions, e.g. IT, Warehousing or Master Data.

She has been working for Bayer since 2009 and is a skilled project manager with nearly 15 years of experience in supply chain management.

Throughout her career, she worked in different roles and projects, gaining valuable insights into Market Supply, Labeling Compliance, Transfer Projects and Bottleneck Management.

Her studies in business administration have provided her with a solid foundation for her professional journey. Recently, she also completed the Lean Six Sigma Green Belt certification, further enhancing her skills in process optimization.

René Reuter is Senior Product Owner & Manager Software at Körber BA Pharma. The engineering & informatics graduate joined Körber as Project Engineer in 2017. In this position, he was responsible for the continuous development of the PAS-X Track & Trace product, with a strong focus on customer satisfaction. René played a key role in implementing Track & Trace projects globally. Since 2020, he has served as Technical Product Lead, working closely with customers to translate their needs into actionable product requirements. René has also been instrumental in driving the transformation of the PAS-X Track & Trace platform, transitioning it from the legacy 3.1.8 version to a modern cloud-based product, including a SaaS offering.

Our pursuit is progress for people everywhere. That's why we take a closer look at things, ask questions and think ahead. We've been around for 350 years, yet our majority owners are still the descendants of Friedrich Jacob Merck, the man who founded our company in Darmstadt, Germany in 1668. Since then, we have become a truly global company, with 50,000 employees in 66 countries working on breakthrough solutions and technologies. In 2016, we invested a total of € 2.0 billion in research and development. We are Merck. The only exceptions are the United States and Canada. Here we operate as EMD Serono in the Biopharma business, as MilliporeSigma in the Life Science business, and as EMD Performance Materials in the materials business.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognized as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).

Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. A growing and aging world population requires an adequate supply of food and improved medical care. With life expectancy continuing to rise, we improve quality of life for a growing population by focusing our research and development activities on preventing, alleviating and treating diseases. We are also making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials.

Körber is an international technology group with more than 12,000 employees at over 100 locations worldwide and a common goal: We turn entrepreneurial thinking into customer success and shape the technological change. In the Business Areas Digital, Pharma, Supply Chain, and Technologies, we offer products, solutions and services that inspire. We act fast to customer needs, we execute ideas seamlessly, and with our innovations we create added value for our customers. In doing so, we are increasingly building on ecosystems that solve the challenges of today and tomorrow. Körber AG is the holding company of the Körber Group. At the Körber Business Area Pharma we are delivering the difference along the pharma value chain with our unique portfolio of integrated solutions. With our software solutions we help drug manufacturers to digitalize their pharmaceutical, biotech and cell & gene therapy production. The Werum PAS-X MES Suite is recognized as the world’s leading Manufacturing Execution System for pharma, biotech and cell & gene. Our Werum PAS-X Savvy Suite accelerates product commercialization with data analytics and AI solutions and uncovers hidden business value. www.koerber-pharma.com